Fig. 7

Mass cytometry revealed changes in marker expression after PBS/MDZ treatment. A–G TSNE plot showing the distribution of PD1, PD-L1, TIGIT, TIM3, ICOS, IFN-g and TNF-α expression in subcutaneous Hepa1-6 tumours in the PBS and MDZ groups. H The histogram shows the number of PD1⁺, CD8⁺PD1⁺, Treg⁺ PD1⁺, PD-L1⁺, MDSC⁺ PD-L1⁺, TIGIT, TIM3, ICOS, IFN-g⁺, and TNF-α⁺ cell clusters in the PBS and MDZ groups